目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T60330 | |||
Metapramine (19560 RP) 是一种三环类抗抑郁剂。Metapramine 抑制去甲肾上腺素 (norepinephrine) 的再摄取,而不影响血清素或多巴胺的再摄取。Metapramine 是 N-methyl-D-aspartic acid (NMDA) 受体复合物通道的低亲和力拮抗剂。 | |||
T7433 | Others | ||
2-Phenylethylamine hydrochloride (benzeneethanamine hydrochloride) 是神经调节剂或神经递质。 | |||
T22420 | Norepinephrine | ||
(S)-Viloxazine Hydrochloride 是Viloxazine 的S 异构体。Viloxazine 是一种选择性去甲肾上腺素再摄取抑制剂(NRI),可用作抗抑郁药。 | |||
T4761 | Others Endogenous Metabolite | ||
Pyridoxal hydrochloride 是内源性代谢产物的一种。 | |||
T12232 | Serotonin Transporter | ||
Nitroxazepine (CIBA 2330Go) 是三环抗抑郁化合物,是一种 5-羟色胺去甲肾上腺素再摄取抑制剂,可用于抗抑郁的研究。 | |||
T22413 | Others | ||
(R)-Viloxazine Hydrochloride 是 Viloxazine 的 R 型异构体,Viloxazine 是一种选择性去甲肾上腺素再摄取抑制剂(NRI),可用作抗抑郁药。 | |||
T5229 | Others | ||
DL -3,4-Dihydroxymandelic acid 是去甲肾上腺素在人体中的次要代谢物。神经母细胞瘤患者的 3,4-二羟基扁桃酸水平升高。 | |||
T32737 | Dopamine Receptor 5-HT Receptor Norepinephrine | ||
Liafensine(BMS-820836) 是一种新型且具有选择性的三重单胺再摄取抑制剂,对血清素、去甲肾上腺素和多巴胺的再摄取具有抑制作用,可用于研究重度抑郁症和中枢神经系统疾病。 | |||
T2547 | Adrenergic Receptor | ||
Droxidopa (L-DOPS) 是 Droxidopa (w/w80%) 和 Pharmaceutical starch (w/w20%) 的混合物,能透过血脑屏障,可作为神经递质去甲肾上腺素和肾上腺素的原药。 | |||
T2594 | Serotonin Transporter Norepinephrine | ||
Dextromilnacipran (Levomilnacipran) 是米那普仑的对映体,是一种选择性 5- 羟色胺和去甲肾上腺素(5-HT/NE)再摄取抑制剂,也是一种人类 α 肾上腺素能受体拮抗剂,IC50=3.4 μM。 |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPY-03852 | Dopamine beta-Hydroxylase Protein, Human, Recombinant (His) | Human | HEK293 | ||
DBH is a 29 kDa copper-containing oxygenase. It can be detected in noradrenergic nerve terminals of the central and peripheral nervous systems, and is also expressed in chromaffin cells of the adrenal medulla. DBH contains our identical subunits, and its activity requires ascorbate as a cofactor. It functions in in the synthesis of small-molecule neurotransmitters that is membrane-bound, making norepinephrine the only transmitter synthesized inside vesicles. DBH has been shown to be associated with decision making and addictive behaviors such as alcohol and smoking, attention deficit hyperactivity disorder, and also with neurological diseases such as Schizophrenia and Alzheimer's.
|
|||||
TMPY-02948 | SULT1A3 Protein, Human, Recombinant (His) | Human | E. coli | ||
SULT1A3 belongs to the sulfotransferase 1 family. Sulfotransferase enzymes catalyze the sulfate conjugation of many hormones, neurotransmitters, drugs, and xenobiotic compounds. They are different in their tissue distributions and substrate specificities while their gene structure (number and length of exons) is similar. SULT1A3 gene encodes a phenol sulfotransferase with thermolabile enzyme activity. Four sulfotransferase genes are located on the p arm of chromosome 16; this gene and SULT1A4 arose from a segmental duplication. It is the most centromeric of the four sulfotransferase genes. Exons of this gene overlap with exons of a gene that encodes a protein containing GIY-YIG domains (GIYD1). SULT1A3 is expressed in liver, colon, kidney, lung, brain, spleen, small intestine, placenta and leukocyte. SULT1A3 is a sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the sulfate conjugation of phenolic monoamines (neurotransmitters such as dopamine, norepinephrine and serotonin) and phenolic and catechol drugs.
|